0001883850-22-000068.txt : 20220912
0001883850-22-000068.hdr.sgml : 20220912
20220912163144
ACCESSION NUMBER: 0001883850-22-000068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220908
FILED AS OF DATE: 20220912
DATE AS OF CHANGE: 20220912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bassler Bonnie L
CENTRAL INDEX KEY: 0001683607
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 221238915
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-09-08
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001683607
Bassler Bonnie L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2022-09-08
4
M
0
1279
391.92
A
2361
D
Common Stock
2022-09-08
4
S
0
1279
705.0
D
1082
D
Common Stock
2022-09-08
4
M
0
1279
391.92
A
2361
D
Common Stock
2022-09-08
4
S
0
1279
686.99
D
1082
D
Common Stock
2022-09-09
4
M
0
609
376.69
A
1691
D
Common Stock
2022-09-09
4
S
0
609
741.0
D
1082
D
Non-Qualified Stock Option (right to buy)
376.69
2022-09-09
4
M
0
609
0.0
D
2027-01-03
Common Stock
609
610
D
Non-Qualified Stock Option (right to buy)
391.92
2022-09-08
4
M
0
1279
0.0
D
2026-09-09
Common Stock
1279
3839
D
Non-Qualified Stock Option (right to buy)
391.92
2022-09-08
4
M
0
1279
0.0
D
2026-09-09
Common Stock
1279
2560
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 1,279 shares of Company stock on September 8, 2022 at prices ranging from $705.00 to $705.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 8, 2022 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/** Bonnie L. Bassler
2022-09-09